Prostate cancer is most common in men over the age of 65 and is rated as the second most common cause of cancer-related death in males. While early detection often results in survival, when the cancer is discovered later, or it has spread elsewhere in the body, the chances of survival decrease dramatically.

Leukaemia is another form of cancer that claims many lives each year. While the overall five-year survival rate has quadrupled since the 1960s, leukaemia still kills over 24,000 people annually.
Conventional treatment options for these forms of cancer are debilitating and can result in many short- and long-term side effects. Now, a study conducted by researchers from Dharma Biomedical LLC and the Department of Pathology at Miami Children’s Hospital, published in the journal BMC Complementary and Alternative Medicine, has found that modified citrus pectin (MCP) can enhance the benefits of natural killer (NK) and…
View original post 476 more words
Discover more from Environmental Health Watch NZ
Subscribe to get the latest posts sent to your email.
One thought on “Modified Citrus Pectin Can Inhibit The Growth And Metastasis Of Prostate Cancer And Kill Leukemia Cells”